iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, will present a corporate overview at the 40th Annual Cowen Healthcare Conference, taking place March 2-4, 2020 in Boston, MA.
NASHUA, N.H., Feb. 12, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, will present a corporate overview at the 40th Annual Cowen Healthcare Conference, taking place March 2-4, 2020 in Boston, MA.
| Presentation Details: | |
| Date: | March 4, 2020 |
| Time: | 8:00am Eastern Time |
| Webcast: | http://wsw.com/webcast/cowen57/icad/ |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com
